Because Virginia Cancer Specialists is committed to providing the best available care to all of its patients, research is and will continue to be the cornerstone of the organization. Such research offers patients access to new investigational drugs not always available to the general public.
VCS participates in many clinical trials, which show us what works (and what doesn’t) in medicine. They are the best way for doctors to learn what is safe and effective in treating diseases such as cancer. Such research offers VCS access to new investigational drugs, reduces treatment-related side effects and introduces new methods of care.
As part of its cutting-edge program, VCS has available to its patients, more than any other program in the Metropolitan D.C. area. VCS has open studies across almost all tumor types, including lung, head and neck, breast, melanoma, lymphoma, bladder, uterine, ovarian, and brain. By restoring the immune system’s recognition of cancer cells, this class of drugs hopes to revolutionize cancer care.
The VCS Research Institute prides itself on providing a quality program right in Northern Virginia. Providing top-notch care and the latest, cutting-edge trials allows the program to study new and potentially life-saving treatments. The VCS Research Institute was recognized by INC Research, LLC, for its outstanding research program and speedy and smooth start-up timelines in 2014.